BioHealth News Archive

“Somewhere past the pandemic” celebrates the 30-year partnership between The National Institutes of Health and The Children’s Inn

“Somewhere past the pandemic” celebrates the 30-year partnership between The National Institutes of Health and The Children’s Inn

“Somewhere past the pandemic” celebrates the 30-year partnership between The National Institutes of Health and The Children's Inn in caring for the children and…

Read More
DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats | Global Biodefense

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats | Global Biodefense

The rapid availability of effective medical countermeasures against chemical exposures, from either accidents or chemical weapons attack, is critical in the treatment of their…

Read More
SBIR Funding Proposals Due to NIH by January 5, 2021: 5 Tips for Your Submission | PilieroMazza PLLC – JDSupra

SBIR Funding Proposals Due to NIH by January 5, 2021: 5 Tips for Your Submission | PilieroMazza PLLC – JDSupra

The Small Business Innovative Research (SBIR) program provides grant or contract funding to small businesses seeking to commercialize innovative technologies. With $3.2 billion allotted…

Read More
Novavax to Provide 40 Million Doses of Its COVID-19 Vaccine Candidate to Australia | The Motley Fool

Novavax to Provide 40 Million Doses of Its COVID-19 Vaccine Candidate to Australia | The Motley Fool

Novavax (NASDAQ:NVAX) announced on Wednesday that it has reached an agreement to provide the Australian government with 40 million doses of its COVID-19 vaccine candidate,…

Read More
Novavax Announces Facility Expansion to Support Global Vaccine Development | Novavax Inc. – IR Site

Novavax Announces Facility Expansion to Support Global Vaccine Development | Novavax Inc. – IR Site

GAITHERSBURG, Md., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced…

Read More
What Floreo’s expansion into ADHD means for the autism-focused virtual reality startup – Washington Business Journal

What Floreo’s expansion into ADHD means for the autism-focused virtual reality startup – Washington Business Journal

Through a partnership with NIH, D.C. virtual reality startup Floreo is expanding from autism spectrum disorder to attention deficit hyperactivity disorder. Image: Floreo's platform…

Read More
Jaan Biotherapeutics Awarded NIH Grant to Advance Cardiac Muscle Regeneration Therapy – MarketWatch

Jaan Biotherapeutics Awarded NIH Grant to Advance Cardiac Muscle Regeneration Therapy – MarketWatch

Sep 05, 2020 (IssueWire via COMTEX) -- San Diego, Sep 5, 2020 (Issuewire.com) - Jaan Biotherapeutics ("JBT"), announced that it has been awarded a…

Read More
Rexahn Pharmaceuticals Announces Stockholder Approval of All Proposals Required for Merger with Ocuphire Pharma :: Rexahn Pharmaceuticals, Inc. (REXN)

Rexahn Pharmaceuticals Announces Stockholder Approval of All Proposals Required for Merger with Ocuphire Pharma :: Rexahn Pharmaceuticals, Inc. (REXN)

ROCKVILLE, Md., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN) (“Rexahn”) announced today that at its special meeting of stockholders held on…

Read More
Neuraly Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 2B Trial of NLY01 for Patients with Alzheimer’s Disease | Business Wire

Neuraly Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 2B Trial of NLY01 for Patients with Alzheimer’s Disease | Business Wire

GAITHERSBURG, Md.--(BUSINESS WIRE)--Neuraly, Inc., a clinical stage biotechnology company pioneering disease-modifying agents for neurodegenerative disorders, today announced it has received clearance of an investigational…

Read More
Emmes Employees Co-Author COVID-19 Vaccine Report for the New England Journal of Medicine | BioSpace

Emmes Employees Co-Author COVID-19 Vaccine Report for the New England Journal of Medicine | BioSpace

Three Emmes employees were among the co-authors of the recent report, "Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults."  The employees are…

Read More
JHU Spinout Thrive Earlier Detection Lands up to $2.15 Billion in Acquisition by Exact Sciences · BioBuzz

JHU Spinout Thrive Earlier Detection Lands up to $2.15 Billion in Acquisition by Exact Sciences · BioBuzz

MADISON, Wis. and CAMBRIDGE, Mass., Oct. 27, 2020 /PRNewswire/ — Exact Sciences Corp. (Nasdaq: EXAS) and Thrive Earlier Detection Corp. (“Thrive”), a healthcare company dedicated to incorporating earlier…

Read More
REGENXBIO to Receive $80.0 Million Milestone Payment from Novartis AG | REGENXBIO Inc.

REGENXBIO to Receive $80.0 Million Milestone Payment from Novartis AG | REGENXBIO Inc.

ROCKVILLE, Md., Oct. 27, 2020 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential…

Read More
Strengths of Our Region: Combating Infectious Diseases Forum Roundup · BioBuzz

Strengths of Our Region: Combating Infectious Diseases Forum Roundup · BioBuzz

Over the past nine months, more than $7 billion in federal money has poured into the BioHealth Capital Region in support of therapies, diagnostics,…

Read More
New Johns Hopkins Center Will Research COVID-19 Immunity – CBS Baltimore

New Johns Hopkins Center Will Research COVID-19 Immunity – CBS Baltimore

ANNAPOLIS (WJZ) — A NIH initiative will fund a new Johns Hopkins center to research COVID-19 immunity as the pandemic continues to affect people…

Read More
Your Health in the “New Normal” of the Pandemic – An Industry Revolutionizing Healthcare As We Know It | Economic Alliance of Greater Baltimore

Your Health in the “New Normal” of the Pandemic – An Industry Revolutionizing Healthcare As We Know It | Economic Alliance of Greater Baltimore

Greater Baltimore is one of few regions ideally suited to pioneer the future of digital health, an industry that will revolutionize healthcare as we…

Read More